Pactiv Evergreen Inc. (PTVE)
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Pactiv Evergreen Inc. (“Pactiv Evergreen”) (NASDAQ: PTVE) and Novolex®. Investors who purchased Pactiv Evergreen and continue to hold to the present are encouraged to obtain additional information and assist the investigation.
Investigation Details
The investigation concerns whether Pactiv Evergreen’s board of directors breached its fiduciary duties and failed to provide relevant information to its shareholders before the merger.
On December 9, 2024, Pactiv Evergreen announced that it had entered into a definitive merger agreement to combine “Novolex®, “creating a leading manufacturer in food, beverage and specialty packaging products.” The Company added, “Under the terms of the agreement, Novolex will acquire Pactiv Evergreen for $18.00 per share in an all-cash transaction valued at $6.7 billion, inclusive of Pactiv Evergreen’s net debt as of September 30, 2024.”
What’s Next?
If you are aware of any facts relating to this investigation or purchased Pactiv Evergreen shares, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]